We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+4.99%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$41B
AUM Growth
+$146M
(+0.36%)
Cap. Flow
-$1.33B
Cap. Flow
% of AUM
-3.25%
Top 10 Holdings %
Top 10 Hldgs %
14.19%
Holding
825
New
119
Increased
275
Reduced
226
Closed
119
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$226M |
| 2 |
AGN
Allergan plc
AGN
|
+$166M |
| 3 |
NRF
NorthStar Realty Finance Corp.
NRF
|
+$152M |
| 4 |
Procter & Gamble
PG
|
+$150M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$142M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$382M |
| 2 |
AGN
Allergan Inc
AGN
|
+$274M |
| 3 |
CF Industries
CF
|
+$189M |
| 4 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$164M |
| 5 |
ROC
ROCKWOOD HLDGS INC
ROC
|
+$162M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.99% |
| 2 | Technology | 12.21% |
| 3 | Financials | 11% |
| 4 | Industrials | 9.97% |
| 5 | Consumer Discretionary | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Western Union
WU
$2.04B
| $16.7M | 0.04% |
804,093
| – | – |
|
452
Newmont
NEM
$99.3B
| $16.7M | 0.04% |
770,400
+25,800
| +3% | +$603K |
|
|
ITCI
453
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $16.7M | 0.04% |
700,000
-100,000
| -13% | -$2.24M |
|
454
Kimco Realty
KIM
$17.2B
| $16.6M | 0.04% |
616,563
| – | – |
|
|
ZNGA
455
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $16.5M | 0.04% |
5,800,000
+2,800,000
| +93% | +$7.23M |
|
456
CBRE Group
CBRE
$42.4B
| $16.5M | 0.04% |
426,200
+17,000
| +4% | +$586K |
|
457
Merit Medical Systems
MMSI
$5.13B
| $16.4M | 0.04% |
850,000
+187,558
| +28% | +$3.34M |
|
458
C.H. Robinson
CHRW
$17.2B
| $16.3M | 0.04% |
222,700
+7,500
| +3% | +$548K |
|
|
TGNA
459
DELISTED
TEGNA Inc
TGNA
| $16.1M | 0.04% |
829,593
+181,597
| +28% | +$3.21M |
|
|
INSY
460
DELISTED
Insys Therapeutics, Inc.
INSY
| $16M | 0.04% |
550,000
-13,124
| -2% | -$347K |
|
461
Perrigo
PRGO
$1.45B
| $15.7M | 0.04% |
95,131
+19,200
| +25% | +$3.06M |
|
462
Molson Coors Class B
TAP
$7.88B
| $15.7M | 0.04% |
211,405
| – | – |
|
463
Toro Company
TTC
$8.95B
| $15.6M | 0.04% |
444,596
+3,490
| +0.8% | +$116K |
|
464
Sanofi
SNY
$103B
| $15.6M | 0.04% |
315,000
+50,000
| +19% | +$2.39M |
|
465
Wynn Resorts
WYNN
$10.1B
| $15.5M | 0.04% |
123,400
+1,700
| +1% | +$243K |
|
466
Liberty Broadband Class A
LBRDA
$4.99B
| $15.5M | 0.04% |
+275,000
| New | +$14M |
|
467
Oneok
OKE
$55.7B
| $15.4M | 0.04% |
+318,906
| New | +$14.6M |
|
|
CKEC
468
DELISTED
Carmike Cinemas Inc
CKEC
| $15.2M | 0.04% |
453,766
+103,766
| +30% | +$3.08M |
|
469
Principal Financial Group
PFG
$24.7B
| $15M | 0.04% |
292,549
-159,300
| -35% | -$8.01M |
|
470
EPAM Systems
EPAM
$5.47B
| $15M | 0.04% |
245,000
+75,000
| +44% | +$4.07M |
|
471
RH
RH
$3.18B
| $14.9M | 0.04% |
+150,000
| New | +$13.6M |
|
472
Gerdau
GGB
$9.68B
| $14.7M | 0.04% |
+5,796,000
| New | +$16.1M |
|
|
SQBK
473
DELISTED
SQUARE 1 FINANCIAL INC COM
SQBK
| $14.7M | 0.04% |
547,500
+20,000
| +4% | +$501K |
|
|
TTPH
474
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $14.7M | 0.04% |
20,000
| – | – |
|
475
Ball Corp
BALL
$17.4B
| $14.6M | 0.04% |
414,240
| – | – |
|
Similar funds
Adage Capital Partners's Q1 2015 Portfolio in Review
As of Q1 2015, Adage Capital Partners held 825 positions worth $41B, up 0.36% from $40.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Adage Capital Partners withdrew a net $1.33B in Q1 2015, closing 119 positions and reducing 226 holdings. Its most notable exit was COVIDIEN PLC COM SHS NEW (IRELAND), an estimated $382M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Financials.
Against the trend, Adage Capital Partners opened a new position in Medtronic worth $232M.
- Adage Capital Partners's largest Q1 2015 buy was Medtronic: 2,976,347 shares worth $232M.
- Adage Capital Partners added most to Allergan plc in Q1 2015, an estimated $166M increase.
- Adage Capital Partners's biggest Q1 2015 reduction was MALLINCKRODT PUBLIC LIMITED COMPANY, cutting an estimated $164M.
- Adage Capital Partners fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $382M.
- Adage Capital Partners's ten largest holdings make up 14% of its $41B portfolio in Q1 2015.
- Adage Capital Partners opened 119 new positions and closed 119 in Q1 2015.
- Adage Capital Partners's portfolio value rose 0.36% quarter-over-quarter to $41B.
Based on Adage Capital Partners's 13F filing for Q1 2015, filed 15 May 2015.